As a result, Humana anticipates $16.44 earnings per share, down 6.7 percent from its previous outlook, Insider Louisville reports.
Humana’s shares fell on the news, as well as on reports it will lose about 300,000 prescription drug plan members in 2018. The payer’s shares decreased 2.5 percent Monday to a low of $257, recovering slightly to close at $258.55, Insider Louisville reports.
More articles on payer issues:
Trump administration moves to allow health insurance sales across state lines: 3 things to know
Centene adds 1.4M members during open enrollment 2018
5 payers in the headlines
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
